Ramsay Health Care (OTCMKTS:RMYHY) versus Oncology Institute (NASDAQ:TOI) Financial Review

Ramsay Health Care (OTCMKTS:RMYHY) and Oncology Institute (NASDAQ:TOI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Institutional & Insider Ownership

36.9% of Oncology Institute shares are owned by institutional investors. 4.4% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Ramsay Health Care and Oncology Institute’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ramsay Health Care	N/A	N/A	N/A
Oncology Institute	-7.42%	N/A	-24.68%

Earnings and Valuation

This table compares Ramsay Health Care and Oncology Institute”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ramsay Health Care	N/A	N/A	N/A	N/A	N/A
Oncology Institute	$502.73 million	0.99	-$60.61 million	($0.37)	-13.59

Ramsay Health Care has higher earnings, but lower revenue than Oncology Institute.

Volatility and Risk

Ramsay Health Care has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Ramsay Health Care and Oncology Institute, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ramsay Health Care	1	1	0	0	1.50
Oncology Institute	1	0	4	0	2.60

Oncology Institute has a consensus target price of $7.75, suggesting a potential upside of 54.08%. Given Oncology Institute’s stronger consensus rating and higher probable upside, analysts plainly believe Oncology Institute is more favorable than Ramsay Health Care.

Summary

Oncology Institute beats Ramsay Health Care on 7 of the 9 factors compared between the two stocks.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

About Oncology Institute

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.